Skip to main content
$6.79 $0.13 (2.0%)

04:00 PM EDT on 05/19/22

DermTech, Inc. (NASDAQ:DMTK)

CAPS Rating: 3 out of 5

Current Price $6.79 Mkt Cap $199.4M
Open $6.71 P/E Ratio 0.00
Prev. Close $6.79 Div. (Yield) $0.00 (0.0%)
Daily Range $6.67 - $7.08 Volume 836,809
52-Wk Range $6.39 - $48.32 Avg. Daily Vol. 783,137

Caps

How do you think NASDAQ:DMTK will perform against the market?

Add Stock to CAPS Watchlist

All Players

242 Outperform
6 Underperform
 

All-Star Players

17 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DMTK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TomFoolNC (37.32)
Submitted October 13, 2021

seems like a game changer, surprised sales not taking off faster then they are

naughtyguy (59.64)
Submitted February 24, 2021

Correction overdue

NASDAQ:DMTK VS S&P 500 (SPY)

NASDAQ:DMTK Summary

Fools bullish on NASDAQ:DMTK are also bullish on:

Fools bearish on NASDAQ:DMTK are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about DMTK.

Recs

0
Member Avatar Ransom65 (21.67) Submitted: 4/18/2022 5:42:38 PM : Outperform Start Price: $11.12 NASDAQ:DMTK Score: -27.87

DMTK has already gained FDA approval for its Melanoma sticker diagnostic technology they also own ALL patents on its tech. They are also in the process of completing phase 3 trials for the same sticker technology for the other two most common skin cancers Basal Cell and squeamish cell carcinomas with FDA approval for these they have the trifecta on ALL skin cancers for non invasive testing with 99.9% accuracy. DMTK has also made in roads with insurance companies Medicare as well as Anthem. Cost: The standard for diagnosing skin cancers are expensiveness and invasive biopsies the average cost to insurance companies is $2000 for this. DMTK's patch technology is 99.9% accurate and it's cost to insurance companies is under $800 thus saving insurers huge sums of money.As well as patients the pain and scaring of unnecessary biopsies. I see insurance companies not only coming on board with DMTK but making it a requirement for doctors to use the patch first biopsy second meaning if a doctor does a biopsy when the patch could have been used the billing will be rejected by the insurer. These are but a few of the ways DMTK will change the market over the next ten years. My wife and I hold a large position in DMTK and for us we see this is a 10X profit stock by 2030.

Recs

0
Member Avatar Tschiti (55.60) Submitted: 3/16/2022 7:31:23 AM : Outperform Start Price: $12.28 NASDAQ:DMTK Score: -35.28

- interesting market
- good position in the market

Recs

1
Member Avatar TomFoolNC (37.32) Submitted: 10/13/2021 3:22:23 PM : Outperform Start Price: $31.57 NASDAQ:DMTK Score: -68.08

seems like a game changer, surprised sales not taking off faster then they are

Leaderboard

Find the members with the highest scoring picks in DMTK.

Score Leader

Kderick10

Kderick10 (< 20) Score: +111.54

The Score Leader is the player with the highest score across all their picks in DMTK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
IndyAnthony < 20 10/27/2021 Underperform 5Y $28.65 -76.30% -14.69% +61.61 0 Comment
Bigcaps19 88.99 1/14/2022 Underperform 5Y $13.88 -51.08% -15.49% +35.59 0 Comment
jon5555 93.80 2/24/2022 Underperform 5Y $10.74 -36.78% -5.26% +31.51 0 Comment
funcioneitor 95.30 5/10/2022 Outperform 5Y $6.78 +0.22% -1.56% +1.78 0 Comment
jonboy13 91.84 5/10/2022 Underperform 5Y $7.00 -3.00% -2.43% +0.57 0 Comment
TMFJoryko 86.53 5/19/2022 Outperform 5Y $6.81 -0.29% -0.83% +0.54 0 Comment
Jonnyboy5555 84.40 5/11/2022 Underperform 5Y $6.91 -1.74% -2.18% -0.45 0 Comment
wsmoot8796 74.29 5/19/2022 Underperform 1Y $6.71 +1.19% +0.20% -1.00 0 Comment
tonyk 61.15 5/5/2022 Outperform 5Y $8.06 -15.76% -5.63% -10.13 0 Comment
Willfire 27.02 1/28/2022 Outperform 5Y $10.53 -35.52% -10.06% -25.46 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DMTK.